Picture of Hanmi Pharm logo

128940 — Hanmi Pharm News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

S.Korea's biotech, pharma stocks rise after revised accounting rule guideline

** South Korea's pharmaceutical and biotechnology firms
rise; pharmaceutical index  .KS32  rises 2.8 pct
    ** Country's top financial regulator said on Wednesday it
had revised accounting rule guideline, easing market uncertainty
    ** The Financial Services Commission (FSC) said it would
allow companies to correct accounting errors and treat research
and development (R&D) spending as an asset if a new drug is
technically viable, under specific standards
    ** Shares of Samsung Biologics Co Ltd  207940.KS  and Hanmi
Pharm Co Ltd  128940.KS  climb 4.7 pct and 2.8 pct,
respectively, while pharmaceutical giant Celltrion Inc
 068270.KS  gains as much as 1.8 pct
    ** Samsung Biologics also boosted by a recent rise in sales
contracts, says Kang Yang-ku, an analyst at Hyundai Motor
Investment & Securities
    ** Broader market  .KS11  up 0.7 pct as of 0233 GMT

 ((joori.roh.thomsonreuters.com@reuters.net))

Recent news on Hanmi Pharm

See all news